All lobbying filings
CAREDX, INC.
Lobbying for CAREDX, INC. · Clinical laboratory and transplant support services
Filing
1st Quarter - Report
Lobbying activity
2
-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests
Living Donor Protection Act (LDPA) S1522, HR4582,HR4583